Unknown

Dataset Information

0

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.


ABSTRACT: Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.Methods: An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and compared with patients without ILD, obtained from the ISARIC4C (International Severe Acute Respiratory and Emerging Infection Consortium Coronavirus Clinical Characterisation Consortium) cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished idiopathic pulmonary fibrosis from non-idiopathic pulmonary fibrosis ILD and used lung function to determine the greatest risks of death.Measurements and Main Results: Data from 349 patients with ILD across Europe were included, of whom 161 were admitted to the hospital with laboratory or clinical evidence of COVID-19 and eligible for propensity score matching. Overall mortality was 49% (79/161) in patients with ILD with COVID-19. After matching, patients with ILD with COVID-19 had significantly poorer survival (hazard ratio [HR], 1.60; confidence interval, 1.17-2.18; P = 0.003) than age-, sex-, and comorbidity-matched controls without ILD. Patients with an FVC of <80% had an increased risk of death versus patients with FVC ≥80% (HR, 1.72; 1.05-2.83). Furthermore, obese patients with ILD had an elevated risk of death (HR, 2.27; 1.39-3.71).Conclusions: Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD.

SUBMITTER: Drake TM 

PROVIDER: S-EPMC7737581 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.

Drake Thomas M TM   Docherty Annemarie B AB   Harrison Ewen M EM   Quint Jennifer K JK   Adamali Huzaifa H   Agnew Sarah S   Babu Suresh S   Barber Christopher M CM   Barratt Shaney S   Bendstrup Elisabeth E   Bianchi Stephen S   Villegas Diego Castillo DC   Chaudhuri Nazia N   Chua Felix F   Coker Robina R   Chang William W   Crawshaw Anjali A   Crowley Louise E LE   Dosanjh Davinder D   Fiddler Christine A CA   Forrest Ian A IA   George Peter M PM   Gibbons Michael A MA   Groom Katherine K   Haney Sarah S   Hart Simon P SP   Heiden Emily E   Henry Michael M   Ho Ling-Pei LP   Hoyles Rachel K RK   Hutchinson John J   Hurley Killian K   Jones Mark M   Jones Steve S   Kokosi Maria M   Kreuter Michael M   MacKay Laura S LS   Mahendran Siva S   Margaritopoulos George G   Molina-Molina Maria M   Molyneaux Philip L PL   O'Brien Aiden A   O'Reilly Katherine K   Packham Alice A   Parfrey Helen H   Poletti Venerino V   Porter Joanna C JC   Renzoni Elisabetta E   Rivera-Ortega Pilar P   Russell Anne-Marie AM   Saini Gauri G   Spencer Lisa G LG   Stella Giulia M GM   Stone Helen H   Sturney Sharon S   Thickett David D   Thillai Muhunthan M   Wallis Tim T   Ward Katie K   Wells Athol U AU   West Alex A   Wickremasinghe Melissa M   Woodhead Felix F   Hearson Glenn G   Howard Lucy L   Baillie J Kenneth JK   Openshaw Peter J M PJM   Semple Malcolm G MG   Stewart Iain I   Jenkins R Gisli RG  

American journal of respiratory and critical care medicine 20201201 12


<b>Rationale:</b> The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.<b>Objectives:</b> To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.<b>Methods:</b> An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and c  ...[more]

Similar Datasets

| S-EPMC8250536 | biostudies-literature
| S-EPMC10524033 | biostudies-literature
| S-EPMC8908865 | biostudies-literature
| S-EPMC8461362 | biostudies-literature
| S-EPMC8907778 | biostudies-literature
| S-EPMC7737597 | biostudies-literature
2022-05-03 | GSE201790 | GEO
| S-EPMC7997249 | biostudies-literature
| S-EPMC8086543 | biostudies-literature